Identifying mutation specific cancer pathways using a structurally resolved protein interaction network

Pacific Symposium on Biocomputing

Volumn , Issue , 2015, Pages 84-95

  Engin, H Billur ^a   Hofree, Matan ^b   Carter, Hannah ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; DISEASES;

FUNCTIONAL PREDICTIONS; INTERACTION PROFILES; INTERFACE RESIDUES; PROTEIN DATA BANK; PROTEIN INTERACTION; PROTEIN INTERACTION NETWORKS; PROTEIN STRUCTURES; PROTEIN-PROTEIN INTERACTIONS;

PROTEINS;

HRAS PROTEIN, HUMAN; PROTEIN P21; TUMOR PROTEIN;

ALGORITHM; BIOLOGY; CHEMISTRY; GENETICS; HUMAN; MOLECULAR MODEL; MUTATION; NEOPLASMS; ONCOGENE; PERSONALIZED MEDICINE; PHENOTYPE; PROTEIN DATABASE; PROTEIN PROTEIN INTERACTION; STATISTICS AND NUMERICAL DATA;

ALGORITHMS; COMPUTATIONAL BIOLOGY; DATABASES, PROTEIN; HUMANS; MODELS, MOLECULAR; MUTATION; NEOPLASM PROTEINS; NEOPLASMS; ONCOGENES; PHENOTYPE; PRECISION MEDICINE; PROTEIN INTERACTION MAPS; PROTO-ONCOGENE PROTEINS P21(RAS);

EID: 84962882861     PISSN: 23356928     EISSN: 23356936     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (55)

1. Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546-1558, doi:10.1126/science.1235122 (2013).
2. Garraway, L. A.&Lander, E. S. Lessons from the cancer genome. Cell 153, 17-37, doi:10.1016/j.cell.2013.03.002 (2013).
3. Ideker, T., Ozier, O., Schwikowski, B.&Siegel, A. F. Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics 18 Suppl 1, S233-240 (2002).
4. Akula, N. et al. A network-based approach to prioritize results from genome-wide association studies. PloS one 6, e24220, doi:10.1371/journal.pone.0024220 (2011).
5. Vandin, F., Upfal, E.&Raphael, B. J. Algorithms for detecting significantly mutated pathways in cancer. Journal of computational biology : a journal of computational molecular cell biology 18, 507-522, doi:10.1089/cmb.2010.0265 (2011).
6. Cerami, E., Demir, E., Schultz, N., Taylor, B. S.&Sander, C. Automated network analysis identifies core pathways in glioblastoma. PloS one 5, e8918, doi:10.1371/journal.pone.0008918 (2010).
7. Hofree, M., Shen, J. P., Carter, H., Gross, A.&Ideker, T. Network-based stratification of tumor mutations. Nature methods 10, 1108-1115, doi:10.1038/nmeth.2651 (2013).
8. Mosca, R., Ceol, A.&Aloy, P. Interactome3D: adding structural details to protein networks. Nature methods 10, 47-53, doi:10.1038/nmeth.2289 (2013).
9. Wang, X. et al. Three-dimensional reconstruction of protein networks provides insight into human genetic disease. Nature biotechnology 30, 159-164, doi:10.1038/nbt.2106 (2012).
10. David, A., Razali, R., Wass, M. N.&Sternberg, M. J. Protein-protein interaction sites are hot spots for disease-associated nonsynonymous SNPs. Human mutation 33, 359-363, doi:10.1002/humu.21656 (2012).
11. Engin, H. B., Guney, E., Keskin, O., Oliva, B.&Gursoy, A. Integrating structure to proteinprotein interaction networks that drive metastasis to brain and lung in breast cancer. PloS one 8, e81035, doi:10.1371/journal.pone.0081035 (2013).
12. Acuner-Ozbabacan , S. E. et al. The structural network of Interleukin-10 and its implications in inflammation and cancer. BMC Genomics 15, S2 (2014).
13. Acuner Ozbabacan, S. E., Gursoy, A., Nussinov, R.&Keskin, O. The structural pathway of interleukin 1 (IL-1) initiated signaling reveals mechanisms of oncogenic mutations and SNPs in inflammation and cancer. PLoS computational biology 10, e1003470, doi:10.1371/journal.pcbi.1003470 (2014).
14. Zhong, Q. et al. Edgetic perturbation models of human inherited disorders. Molecular systems biology 5, 321, doi:10.1038/msb.2009.80 (2009).
15. Schuster-Bockler, B.&Bateman, A. Protein interactions in human genetic diseases. Genome biology 9, R9, doi:10.1186/gb-2008-9-1-r9 (2008).
16. Franceschini, A. et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic acids research 41, D808-815, doi:10.1093/nar/gks1094 (2013).
17. Das, J.&Yu, H. HINT: High-quality protein interactomes and their applications in understanding human disease. BMC systems biology 6, 92, doi:10.1186/1752-0509-6-92 (2012).
18. Bernstein, F. C. et al. The Protein Data Bank. A computer-based archival file for macromolecular structures. European journal of biochemistry / FEBS 80, 319-324 (1977).
19. Harrow, J. et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome research 22, 1760-1774, doi:10.1101/gr.135350.111 (2012).
20. Karolchik, D. et al. The UCSC Genome Browser Database. Nucleic acids research 31, 51-54 (2003).
21. Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic acids research 25, 3389-3402 (1997).
22. Martin, A. C. Mapping PDB chains to UniProtKB entries. Bioinformatics 21, 4297-4301, doi:10.1093/bioinformatics/bti694 (2005).
23. Tuncbag, N., Keskin, O.&Gursoy, A. HotPoint: hot spot prediction server for protein interfaces. Nucleic acids research 38, W402-406, doi:10.1093/nar/gkq323 (2010).
24. Zhu, X.&Mitchell, J. C. KFC2: a knowledge-based hot spot prediction method based on interface solvation, atomic density, and plasticity features. Proteins 79, 2671-2683, doi:10.1002/prot.23094 (2011).
25. Hubbard SJ, T. J. NACCESS. Department of Biochemistry and Molecular Biology, University College London (1993).
26. Vanunu, O., Magger, O., Ruppin, E., Shlomi, T.&Sharan, R. Associating genes and protein complexes with disease via network propagation. PLoS computational biology 6, e1000641, doi:10.1371/journal.pcbi.1000641 (2010).
27. Gentleman, R. C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome biology 5, R80, doi:10.1186/gb-2004-5-10-r80 (2004).
28. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, Austria, 2014).
29. Huang da, W., Sherman, B. T.&Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic acids research 37, 1-13, doi:10.1093/nar/gkn923 (2009).
30. Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nature genetics 25, 25-29, doi:10.1038/75556 (2000).
31. Fernandez-Medarde, A.&Santos, E. Ras in cancer and developmental diseases. Genes&cancer 2, 344-358, doi:10.1177/1947601911411084 (2011).
32. Potenza, N. et al. Replacement of K-Ras with H-Ras supports normal embryonic development despite inducing cardiovascular pathology in adult mice. EMBO reports 6, 432-437, doi:10.1038/sj.embor.7400397 (2005).
33. De Roock, W. et al. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. The lancet oncology 11, 753-762, doi:10.1016/S1470-2045(10)70130-3 (2010).
34. Nash, G. F., Walsh, D. C.&Kakkar, A. K. The role of the coagulation system in tumour angiogenesis. The lancet oncology 2, 608-613 (2001).
35. Kioi, M. et al. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. The Journal of clinical investigation 120, 694-705, doi:10.1172/JCI40283 (2010).
36. Gupta, S. K., Lysko, P. G., Pillarisetti, K., Ohlstein, E.&Stadel, J. M. Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. The Journal of biological chemistry 273, 4282-4287 (1998).
37. Carmeliet, P. Mechanisms of angiogenesis and arteriogenesis. Nature medicine 6, 389-395, doi:10.1038/74651 (2000).
38. O'Hayer, K. M., Brady, D. C.&Counter, C. M. ELR+ CXC chemokines and oncogenic Rasmediated tumorigenesis. Carcinogenesis 30, 1841-1847, doi:10.1093/carcin/bgp198 (2009).
39. Chin, L. et al. Essential role for oncogenic Ras in tumour maintenance. Nature 400, 468-472, doi:10.1038/22788 (1999).
40. Pylayeva-Gupta, Y., Grabocka, E.&Bar-Sagi, D. RAS oncogenes: weaving a tumorigenic web. Nature reviews. Cancer 11, 761-774, doi:10.1038/nrc3106 (2011).
41. Tronnier, M., Smolle, J.&Wolff, H. H. Ultraviolet irradiation induces acute changes in melanocytic nevi. The Journal of investigative dermatology 104, 475-478 (1995).
42. Zaidi, M. R. et al. Interferon-gamma links ultraviolet radiation to melanomagenesis in mice. Nature 469, 548-553, doi:10.1038/nature09666 (2011).
43. Bald, T. et al. Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. Nature 507, 109-113, doi:10.1038/nature13111 (2014).
44. Yang, G., Curley, D., Bosenberg, M. W.&Tsao, H. Loss of xeroderma pigmentosum C (Xpc) enhances melanoma photocarcinogenesis in Ink4a-Arf-deficient mice. Cancer research 67, 5649-5657, doi:10.1158/0008-5472.CAN-06-3806 (2007).
45. Tormanen, V. T.&Pfeifer, G. P. Mapping of UV photoproducts within ras proto-oncogenes in UV-irradiated cells: correlation with mutations in human skin cancer. Oncogene 7, 1729-1736 (1992).
46. Buday, L.&Downward, J. Many faces of Ras activation. Biochimica et biophysica acta 1786, 178-187, doi:10.1016/j.bbcan.2008.05.001 (2008).
47. Goncalves, V. et al. A missense mutation in the APC tumor suppressor gene disrupts an ASF/SF2 splicing enhancer motif and causes pathogenic skipping of exon 14. Mutation research 662, 33-36, doi:10.1016/j.mrfmmm.2008.12.001 (2009).
48. Huang, H. et al. APC mutations in sporadic medulloblastomas. The American journal of pathology 156, 433-437, doi:10.1016/S0002-9440(10)64747-5 (2000).
49. Eustermann, S. et al. Combinatorial readout of histone H3 modifications specifies localization of ATRX to heterochromatin. Nature structural&molecular biology 18, 777-782, doi:10.1038/nsmb.2070 (2011).
50. Kourmouli, N., Sun, Y. M., van der Sar, S., Singh, P. B.&Brown, J. P. Epigenetic regulation of mammalian pericentric heterochromatin in vivo by HP1. Biochemical and biophysical research communications 337, 901-907, doi:10.1016/j.bbrc.2005.09.132 (2005).
51. Levran, O. et al. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nature genetics 37, 931-933, doi:10.1038/ng1624 (2005).
52. Roy, R., Chun, J.&Powell, S. N. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nature reviews. Cancer 12, 68-78, doi:10.1038/nrc3181 (2012).
53. Carvalho, M. A. et al. Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis. Cancer research 67, 1494-1501, doi:10.1158/0008-5472.CAN-06-3297 (2007).
54. Makishima, H. et al. CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors. Leukemia 26, 1547-1554, doi:10.1038/leu.2012.7 (2012).
55. Zhang, Z., Elly, C., Qiu, L., Altman, A.&Liu, Y. C. A direct interaction between the adaptor protein Cbl-b and the kinase zap-70 induces a positive signal in T cells. Current biology : CB 9, 203-206 (1999).